Monashee Investment Management LLC Xilio Therapeutics, Inc. Transaction History

Monashee Investment Management LLC

  • $704 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$2.08 - $7.2 $339,177 - $1.17 Million
-163,066 Closed
0 $0
Q1 2022

May 12, 2022
SELL
$6.63 - $16.05 $339,369 - $821,551
-51,187 Reduced 23.89%
163,066 $1.15 Million
Q4 2021

Feb 07, 2022
BUY
$9.69 - $25.11 $2.08 Million - $5.38 Million
214,253 New
214,253 $3.43 Million

Others Institutions Holding XLO

# of Institutions
33
Shares Held
12.6M
Call Options Held
0
Put Options Held
0
View Full List

About Xilio Therapeutics, Inc.

XLO Quotes by TradingView
  • Ticker XLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,471,600
  • Market Cap $20.9M
  • Description
  • Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors. The company also develops cytokine prog...
More about XLO
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email